Target intelligence / Profile preview

Increased cervical mucus viscosity

Molecular classification
Other (physiological property, not a molecule or receptor)
01

Overview

"Increased cervical mucus viscosity" is not a molecular target, receptor, enzyme, or protein. Instead, it describes a physiological state where the consistency of the cervical mucus becomes thicker and less permeable. This change in physical property is primarily regulated by hormonal fluctuations—specifically an increase in progesterone after ovulation—which causes the mucus to become more viscous and form an effective barrier against sperm penetration and pathogens[1][5]. Conversely, estrogen reduces this viscosity during the fertile window to facilitate conception. The underlying molecular components responsible for these changes are large glycoproteins called mucins (such as MUC5AC, MUC5B), water content regulated by ion channels like CFTR and CLCA1, and post-translational modifications such as sialylation of mucin proteins[2][6]. However, "increased cervical mucus viscosity" itself does not refer to any single molecule or druggable entity but rather an emergent property resulting from these molecular processes. Because this entry refers to a property/state rather than a discrete biological target suitable for direct pharmacologic intervention or biomarker development—and because it lacks specificity regarding any particular molecule—it should be flagged as incorrect for use in structured drug-target databases.

Other names
Thickened cervical mucusHigh-viscosity cervical mucusCervical mucus thickening
02

Mechanism of action

Progestins increase cervical mucus viscosity, creating a physical barrier to sperm and thus preventing fertilization[1].

03

Biological functions

Acts as a barrier to sperm migration through the cervix[1][5]Protects against ascending pathogens[2][5]Regulates fertility by modulating sperm access to the uterus[1][3][5]
04

Disease associations

Infertility (when viscosity is abnormally high)[2][3]Potential role in infection susceptibility (as altered viscosity can affect mucosal defense)[2]
05

Interacting drugs

Hormonal contraceptives containing progestins (e.g., norethindrone, levonorgestrel)

1 more in the full profile.

Beyond the preview

Go deeper on Increased cervical mucus viscosity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Increased cervical mucus viscosity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call